Knox Systems, Inc. is thrilled to announce a successful funding round that has raised $6,500,000, marking a significant milestone for our innovative company. As experts in delivering "FedRAMP in 90 Days for 90% less," Knox Systems is redefining the standards for compliance and security in an increasingly regulated digital landscape. This fresh capital injection is set to accelerate our mission of streamlining and simplifying FedRAMP authorization processes for businesses, making high-level security and compliance both affordable and accessible. With these funds, we plan to bolster our already robust technology platform by investing in cutting-edge research and advanced automation tools that further decrease the time and cost required to achieve FedRAMP certification. Moreover, the new investment will empower us to expand our talented team—attracting top industry professionals committed to driving innovation and delivering best-in-class solutions to our clients. Our commitment to efficiency and cost-effectiveness not only speaks to our core promise but also demonstrates the growing market need for rapid, economical compliance solutions. As we move forward, the funding will facilitate strategic partnerships, scale our operations, and enhance customer support while reinforcing our reputation as industry pioneers. This milestone is a testament to the confidence our investors have in our approach and vision. We look forward to transforming the compliance landscape and inviting more organizations to experience secure and efficient FedRAMP certification, all while substantially reducing costs and turnaround time.
Knox Systems Secures $6.5M Seed Round to Revolutionize FedRAMP—90 Days & 90% Less Cost!
Get the full Knox Systems, Inc. company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Anveshan
We are a food-tech startup aiming to provide high quality deeply traceable food products. We leverage technologies based on image processing, spectroscopy, blockchain and IOT to provide the best quality food products made traditionally.
$12.7M Series b
today
Caseway
We are the only enterprise AI form platform that replaces internal R&D and manual workflows by building and maintaining fully integrated automation systems, aligned to your data, your processes, and your long-term success. For document-intensive, compliance-driven organizations in regulated industries like insurance, education, finance, healthcare, and government Compelling reason to buy: Who need AI and automation tailored to their unique forms, workflows, and security environment, without having to shoulder R&D risk or manage AI development internally Product category: Our product is an enterprise document form platform Key benefit: That delivers a fully integrated, continuously improving automation system, built and maintained by experts, without upfront AI build costs Key differentiation: Our product is custom-built for each client’s systems and documents, fully integrated and continuously improved through a long-term partnership model, we maintain, debug, adapt, and align incentives to make it work in the real world.
$1.5M Pre-seed
today
Kubera Health
Kubera’s mission is to power a payment ecosystem where contracts are honored, care is rewarded, and waste is eliminated. We deliver contract and payment intelligence that unifies policies, terms, and claims data into one trusted platform — helping healthcare organizations and their partners build fairer contracts, ensure payments flow as intended, and align incentives across the care ecosystem. As healthcare shifts toward new reimbursement models and risk-sharing arrangements, Kubera is building the payment-intelligence backbone that enables multiple parties to adapt faster, protect margins, and dedicate more resources to patient care.
$6.5M Seed
today
Psilera
Psilera is a biotechnology company founded by scientists dedicated to finding better therapeutics for neurological conditions like dementia, addiction, and mental health disorders. Since 2019, Psilera has been focused on early-stage drug discovery & development with a dynamic team of experts in synthetic chemistry, pharmacology, clinical development, and business development.
$8.8M Seed
today
Abstract
Abstract is a venture capital firm based in San Francisco with $1.5 billion in assets under management. We are sector-agnostic, focused on seed and early stage founders. Our reputation among founders is built on fierce loyalty, unparalleled connections, and a relentless drive to help them win.
$59.0M Series a
today
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Kubera Health United States | Seed | $6.5M | today |
| 2 | Psilera United States | Seed | $8.8M | today |
| 3 |  AlmaBetter India | Seed | $240.0K | today |
| 4 |  CodeIntegrity United States | Seed | $5.0M | today |
| 5 |  kopa.ai Lithuania | Seed | $2.3M | today |